Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Tipo de estudio
Intervalo de año
1.
Journal of Infection and Public Health. 2015; 8 (3): 302-304
en Inglés | IMEMR | ID: emr-168153

RESUMEN

Brucellosis is a zoonotic disease caused by Brucella spp. that is transmitted to humans by the ingestion of unpasteurized milk and other dairy products from infected animals or through close contact with secretions. Crimean-Congo hemorrhagic fever [CCHF] is a tick-borne disease caused by a virus that is transmitted to humans by ixoid tick bites, contact with blood and tissue of infected animals or contact with infected humans. The symptoms of brucellosis are non-specific; it can mimic other diseases. In this paper, we present a case of brucellosis that was initially evaluated as CCHF. We emphasize that brucellosis should be considered in the differential diagnosis of CCHF, especially in endemic countries


Asunto(s)
Humanos , Femenino , Fiebre Hemorrágica de Crimea , Virus de la Fiebre Hemorrágica de Crimea-Congo
2.
Journal of Infection and Public Health. 2014; 7 (6): 553-556
en Inglés | IMEMR | ID: emr-149035

RESUMEN

Brucellosis is a common zoonotic disease throughout the world. Brucella spp. transmit to humans through contact with fluids of infected animals, especially sheep, cattle, and goats. It is also transmitted by ingestion of fluid-derived products of infected animals, such as unpasteurized milk and cheese. Brucella spp. changes pH level of intracellular environment, so the first treatment approach is to administer antibiotics that have activity in acidic conditions. Anti-brucellosis treatment regimens include doxycycline for children older than eight years old and rifampicin and trimethoprim/sulfamethoxazole [TMP-SMX] combination therapy for children under eight years old, which may be able to act intracellularly under acidic conditions. A TMP-SMX allergy causing anaphylaxis has been reported previously. No alternative anti-brucellosis treatments have been reported in the literature for patients under eight years old with a TMP-SMX allergy. Here, we report a case of a child with brucellosis and a TMP-SMX allergy who was under eight years old at the time of diagnosis and was successfully treated with rifampicin, ciprofloxacin, and gentamicin


Asunto(s)
Humanos , Femenino , Brucelosis/terapia , Trimetoprim , Sulfametoxazol , Anafilaxia , Combinación Trimetoprim y Sulfametoxazol
3.
EMHJ-Eastern Mediterranean Health Journal. 2013; 19 (10): 898-899
en Inglés | IMEMR | ID: emr-159117
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA